Rachna Kasliwal

Summary

Publications

  1. ncbi request reprint Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in England
    Rachna Kasliwal
    Drug Safety Research Unit, Southampton, United Kingdom
    Drug Saf 31:839-50. 2008
  2. doi request reprint Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study
    Rachna Kasliwal
    Drug Safety Research Unit, Southampton, UK
    Drug Saf 32:499-507. 2009
  3. doi request reprint Neuropsychiatric events with varenicline: a modified prescription-event monitoring study in general practice in England
    Yvonne Buggy
    Drug Safety Research Unit, Bursledon Hall, Southampton, SO31 1AA, UK
    Drug Saf 36:521-31. 2013
  4. ncbi request reprint Safety profile of rosuvastatin: results of a prescription-event monitoring study of 11,680 patients
    Rachna Kasliwal
    Drug Safety Research Unit, Southampton, UK
    Drug Saf 30:157-70. 2007
  5. doi request reprint Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide
    Veronika Vlckova
    Drug Safety Research Unit, Southampton, UK
    Drug Saf 32:409-18. 2009
  6. doi request reprint Risk management and outcomes of adverse events to pioglitazone in primary care in the UK: an observational study
    Carole Fogg
    Drug Safety Research Unit, Bursledon Hall, Southampton, UK
    Drug Saf 32:229-37. 2009
  7. ncbi request reprint A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational data
    Rachna Kasliwal
    Drug Safety Research Unit, Southampton, UK
    Drug Saf 28:803-16. 2005

Detail Information

Publications7

  1. ncbi request reprint Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in England
    Rachna Kasliwal
    Drug Safety Research Unit, Southampton, United Kingdom
    Drug Saf 31:839-50. 2008
    ..Pioglitazone belongs to a class of drugs called thiazolidinediones (TZDs) and was launched in the UK in November 2000...
  2. doi request reprint Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study
    Rachna Kasliwal
    Drug Safety Research Unit, Southampton, UK
    Drug Saf 32:499-507. 2009
    ..Regulatory concerns have arisen about psychiatric events associated with varenicline, including depression, suicidal ideation and changes in behaviour/emotion...
  3. doi request reprint Neuropsychiatric events with varenicline: a modified prescription-event monitoring study in general practice in England
    Yvonne Buggy
    Drug Safety Research Unit, Bursledon Hall, Southampton, SO31 1AA, UK
    Drug Saf 36:521-31. 2013
    ..In response to this regulatory warning, the Drug Safety Research Unit conducted a modified prescription-event monitoring (M-PEM) study to monitor the safety of varenicline...
  4. ncbi request reprint Safety profile of rosuvastatin: results of a prescription-event monitoring study of 11,680 patients
    Rachna Kasliwal
    Drug Safety Research Unit, Southampton, UK
    Drug Saf 30:157-70. 2007
    ..Our objective was to monitor the post-marketing safety of this drug, prescribed in primary care in England, using prescription-event monitoring...
  5. doi request reprint Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide
    Veronika Vlckova
    Drug Safety Research Unit, Southampton, UK
    Drug Saf 32:409-18. 2009
    ..Furthermore, severe hypoglycaemia may be life threatening. Although hypoglycaemia is more often associated with insulin treatment, oral hypoglycaemic agents have the potential to trigger hypoglycaemia...
  6. doi request reprint Risk management and outcomes of adverse events to pioglitazone in primary care in the UK: an observational study
    Carole Fogg
    Drug Safety Research Unit, Bursledon Hall, Southampton, UK
    Drug Saf 32:229-37. 2009
    ....
  7. ncbi request reprint A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational data
    Rachna Kasliwal
    Drug Safety Research Unit, Southampton, UK
    Drug Saf 28:803-16. 2005
    ....